MARC details
000 -LEADER |
fixed length control field |
03773nam a22005055i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
TR-AnTOB |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20231109085829.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
211119s2022 sz | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783030874841 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/978-3-030-87484-1 |
Source of number or code |
doi |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
TR-AnTOB |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
TR-AnTOB |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
İngilizce |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
WS 21 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJ |
Source |
bicssc |
|
Subject category code |
MED045000 |
Source |
bisacsh |
|
Subject category code |
MJ |
Source |
thema |
096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
Classification number |
WS21EBK |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Baird, John Scott. |
Relator term |
author. |
Relator code |
aut |
-- |
http://id.loc.gov/vocabulary/relators/aut |
245 10 - TITLE STATEMENT |
Title |
Dorothy Hansine Andersen |
Medium |
[electronic resource] : |
Remainder of title |
The Life and Times of the Pioneering Physician-Scientist Who Identified Cystic Fibrosis / |
Statement of responsibility, etc. |
by John Scott Baird. |
250 ## - EDITION STATEMENT |
Edition statement |
1st ed. 2022. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Cham : |
Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
-- |
Imprint: Springer, |
Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Part I: Life before Babies Hospital -- Chapter 1: A beginning -- Chapter 2: Orphaned -- Chapter 3: College and medical school -- Chapter 4: False start -- Chapter 5: A reboot -- Part II: Babies Hospital during the McIntosh Era -- Chapter 6: Historical perspectives -- Chapter 7: Synergy -- Chapter 8: Andy’s abandoned farm -- Chapter 9: Scoring the first goal -- Chapter 10: CF firsts -- Chapter 11: “To Dr. Andersen who has pulled me through many a tough year” -- Chapter 12: McIntosh, pediatric pathology, and Columbia University.-Chapter 13: CF sweat and the Matilda Effect -- Chapter 14: Glycogen storage diseases -- Chapter 15: Celiac disease -- Chapter 16: Randomized, controlled trials -- Chapter 17: Babies Hospital siblings -- Chapter 18: A last decade of CF research -- Chapter 19: Pediatric heart diseases -- Part III: Beyond Babies Hospital and the McIntosh Era -- Chapter 20: Time to enjoy the view -- Chapter 21: A foundation and a club for CF -- Chapter 22: The end of an era -- Chapter 23: Cancer. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
This book chronicles the life and accomplishments of Dorothy Hansine Andersen, a pioneering American pathologist and pediatrician who was the first person to define, diagnose, and treat cystic fibrosis. Divided into three parts, the book begins by detailing Anderson’s early life, including being orphaned as an adolescent, her college career, and her laborious start in the medical field. Part II then examines Andersen’s role in defining the new disease “cystic fibrosis of the pancreas” and her career of active engagement in various clinical pursuits and research, both in pathology and pediatrics. Chapters in this section also discuss the numerous attempts made by others to minimize Andersen’s work through gender bias and the Matilda Effect. The book concludes by reviewing the foundations laid for CF, Andersen’s legacy, and her terminal illness. Featuring an engaging narrative style, Dorothy Hansine Andersen is a historically relevant, invaluable text for anyone interested in the life of Dorothy Anderson and the nascence of cystic fibrosis diagnoses. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Internal medicine. |
|
Topical term or geographic name entry element |
Pediatrics. |
|
Topical term or geographic name entry element |
Internal Medicine. |
|
Topical term or geographic name entry element |
Pediatrics. |
653 #1 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Andersen, Dorothy H (Dorothy Hansine), 1901-1963 |
|
Uncontrolled term |
Pediatricians |
|
Uncontrolled term |
Biography |
|
Uncontrolled term |
History |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-3-030-87484-1">https://doi.org/10.1007/978-3-030-87484-1</a> |
Materials specified |
Springer eBooks |
Public note |
Online access link to the resource |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine |
Koha item type |
E-Book |